MAG Group Holding Real Estate Portfolio Reaches USD 11.9 Billion
MAG Group Holding, the multinational conglomerate incorporating different companies serving diverse sectors, announced its portfolio of current and under development projects across its different real estate subsidiaries has reached USD 11.9 billion.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241128995871/en/
Moafaq Al Gaddah, Founder and Chairman of MAG Group Holding (Photo: AETOSWire)
MAG Group Holding’s real estate subsidiaries include MAG Lifestyle Development, Keturah, Invest Group Overseas (IGO), MBL, Shoumous, Art of Living Mall and MAG Leasing for warehouses.
In his comments, Moafaq Al Gaddah, Founder and Chairman of MAG Group Holding, said: "The UAE's real estate sector is witnessing unprecedented demand, driven by the strategic vision and initiatives of our wise leadership. The government’s ongoing efforts to foster a favorable investment climate have made the UAE a preferred investment destination for global investors. We take pride in our extensive portfolio of developments that cater to diverse audiences, adding value to the already thriving sector. At MAG Group Holding, our mandate is to support the UAE's growth by creating innovative developments and meeting the evolving needs of both residents and investors."
*Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20241128995871/en/
Contacts
Khaled Abu Hishme
khaled@cbpr.me
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Dev4All and Pharmaseed Join Forces in Commercial Cooperation to Boost Preclinical Development Services28.11.2024 07:30:00 CET | Press Release
Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241127719655/en/ Dev4All and Pharmaseed Join Forces in Commercial Cooperation (Graphic: Business Wire) Dev4All, 4P-Pharma's cutting-edge R&D booster, announces a strategic collaboration with Pharmaseed, an established Contract Research Organization (CRO) with over 20 years of expertise in preclinical drug development. This partnership combines the strengths of both organizations to offer an integrated, end-to-end approach for preclinical development. Together, Dev4All and Pharmaseed aim to deliver comprehensive and competitive solutions that accelerate drug development and address the complexities of today’s R&D landscape. With over two decades of experience in CRO services and ten years advancing drug development candidates from TRL3 to TRL5, this close cooperation provides tailored preclinical support, cutting-edge laboratory capabilities, and strategic expert
Galderma’s Phase III OLYMPIA 1 Data Published in JAMA Dermatology Demonstrate That Nemolizumab Improves Core Signs and Symptoms of Prurigo Nodularis28.11.2024 07:00:00 CET | Press Release
Galderma (SWX:GALD) today announced that full results from the phase III OLYMPIA 1 trial, a 24-week study which evaluated the efficacy and safety of nemolizumab monotherapy in adults with moderate-to-severe prurigo nodularis, were published inJAMA Dermatology.1 The trial met both primary and all key secondary endpoints, showing that nemolizumab-treated patients had significantly higher improvements in itch and skin lesions when compared to those receiving placebo at Week 16, with a rapid and clinically meaningful response on itch and sleep disturbance observed as early as Week 4.1 Nemolizumab was well-tolerated, and its safety profile was generally consistent with previous studies.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241127699136/en/ “These results, alongside the OLYMPIA 2 trial data, formed the basis of nemolizumab’s recent U.S. Food and Drug Administration approval for the treatment of adults with prurigo nodul
After Three Successful Years With the IBSA Class40 and Skipper Alberto Bona, IBSA’s Sports Project Comes to an End27.11.2024 15:30:00 CET | Press Release
Three years of intense work, 25,000 miles of racing, five Atlantic crossings, ten regattas, a first and a fourth place in the international Class40 circuit, five podium finishes and two victories: a remarkable human and sporting achievement that combined tenacity, courage, adventure, sustainability and inclusion. This marks the conclusion, after three sporting seasons, of the project that united the multinational pharmaceutical company IBSA with ocean sailor Alberto Bona. An intense journey that began in 2022 with the construction of the Class40 IBSA in France and touched the shores of Brittany, Normandy, England, Ireland, Martinique and Guadeloupe, the United States and Canada. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241127852350/en/ “We experienced three intense years, during which we took the IBSA brand around the world; a sporting project that allowed ingenuity, courage, perseverance and passion to fully manifest”
PUMA Signs Blockbuster Long-Term Partnership With the Portuguese Football Federation27.11.2024 14:47:00 CET | Press Release
Sports company PUMA has signed a long-term agreement with the Portuguese Football Federation (FPF), one of the world’s most popular national teams. Starting in 2025, PUMA will equip all male, female and youth teams as well as the federation’s futsal, beach football and E-Sports teams. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241127980673/en/ Sports company PUMA has signed a long-term agreement with the Portuguese Football Federation (FPF), one of the world’s most popular national teams. Starting in 2025, PUMA will equip all male, female and youth teams as well as the federation’s futsal, beach football and E-Sports teams. (Photo: Business Wire) Portugal, the 2016 European Champions and 2018/19 Nations League Winners, are known for their captivating style of play, which has earned them many fans all over the world and the largest number of followers on social media of any national football federation worldwide. “Signing
Unlock Business Insights with SIX and Syntax27.11.2024 14:00:00 CET | Press Release
SIX, the Swiss-based global financial data expert, announces partnership with Syntax, a leader in innovative financial data and technologies. Starting today, SIX customers can access Syntax’s multi-sector company classifications, offering valuable insights into the intricate business models of thousands of companies worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241127390420/en/ Enhanced Financial Analysis With Syntax’s cutting-edge classifications, SIX now delivers detailed revenue and product line sector data, reflecting the multifaceted nature of modern enterprises. This advanced data, protected by 21 patents, spans over 7,000 companies globally and includes historical data on more than 11,000 companies. Syntax’s standardized approach transforms diverse company reports into a unified language, enabling precise comparisons and in-depth analysis. Financial professionals can now pinpoint business risks inherent in
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom